Income Statement GE HealthCare Technologies Inc.

Equities

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 02:30:00 17/01/2026 am IST			5-day change	1st Jan Change
81.75 ^USD	-0.92%		-5.93%	-0.33%

16/01	Sector Update: Health Care Stocks Softer Late Afternoon	MT
16/01	Sector Update: Health Care	MT

ff5241e0fac17122876e71.FQ8op0Wx4mfPCwgZIrp1ymxGZ2WNONhcLVfJeCC0CN8.ZVoZxHb8lDH5cmJaSuNGrgsqLAjiD4oNTA67K0LQZr1dP2n9FseBD6BEYw

Published financial data: GE HEALTHCARE TECHNOLOGIES INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	1.72TCr	1.76TCr	1.83TCr	1.96TCr	1.97TCr
Total Revenues	1.72TCr	1.76TCr	1.83TCr	1.96TCr	1.97TCr
Cost of Goods Sold, Total	1.04TCr	1.04TCr	1.12TCr	1.16TCr	1.15TCr
Gross Profit	676.7Cr	717.4Cr	717.9Cr	792.2Cr	820.5Cr
Selling General & Admin Expenses, Total	324.1Cr	356.4Cr	362.1Cr	390.6Cr	386.8Cr
R&D Expenses	81Cr	82Cr	102.6Cr	120.5Cr	131.1Cr
Other Operating Expenses, Total	405.1Cr	438Cr	464.7Cr	511.1Cr	517.9Cr
Operating Income	271.6Cr	279.4Cr	253.2Cr	281.1Cr	302.6Cr
Interest Expense, Total	-6.6Cr	-4Cr	-8.6Cr	-50Cr	-46Cr
Interest And Investment Income	4.9Cr	3.4Cr	-	2.6Cr	-
Net Interest Expenses	-1.7Cr	-60L	-8.6Cr	-48Cr	-46Cr
Income (Loss) On Equity Invest.	70L	2.7Cr	1.3Cr	1.1Cr	80L
Currency Exchange Gains (Loss)	-	-	-	-3.7Cr	-4.2Cr
Other Non Operating Income (Expenses)	40L	6Cr	5.3Cr	3.8Cr	3.4Cr
EBT, Excl. Unusual Items	271Cr	287.5Cr	251.2Cr	234.4Cr	256.3Cr
Other Unusual Items	-	-	-	1.7Cr	1.8Cr
EBT, Incl. Unusual Items	271Cr	287.5Cr	251.2Cr	236.1Cr	258.1Cr
Income Tax Expense	65Cr	60Cr	56Cr	74Cr	53Cr
Earnings From Continuing Operations	205.8Cr	227.5Cr	194.9Cr	161.8Cr	205Cr
Earnings Of Discontinued Operations	1.18TCr	1.8Cr	1.8Cr	-40L	-
Net Income to Company	1.39TCr	229.3Cr	196.7Cr	161.4Cr	205Cr
Minority Interest	-5.1Cr	-4.6Cr	-5.1Cr	-23Cr	-5.7Cr
Net Income - (IS)	1.38TCr	224.7Cr	191.6Cr	138.5Cr	199.3Cr
Net Income to Common Incl Extra Items	1.38TCr	224.7Cr	191.6Cr	138.5Cr	199.3Cr
Net Income to Common Excl. Extra Items	200.7Cr	222.9Cr	189.8Cr	138.9Cr	199.3Cr
Per Share Items
Net EPS - Basic	-	-	-	3.04	4.37
Basic EPS - Continuing Operations	-	-	-	3.05	4.37
Basic Weighted Average Shares Outstanding	-	-	-	46Cr	46Cr
Net EPS - Diluted	-	-	-	3.03	4.34
Diluted EPS - Continuing Operations	-	-	-	3.04	4.34
Diluted Weighted Average Shares Outstanding	-	-	-	46Cr	46Cr
Normalized Basic EPS	-	-	-	2.72	3.39
Normalized Diluted EPS	-	-	-	2.7	3.37
Dividend Per Share	-	-	-	0.12	0.12
Payout Ratio	-	-	-	2.96	2.76
Supplemental Items
EBITDA	334.6Cr	341.9Cr	316.5Cr	342.1Cr	360.6Cr
EBITA	312.4Cr	319.4Cr	293.7Cr	317.3Cr	333.8Cr
EBIT	271.6Cr	279.4Cr	253.2Cr	281.1Cr	302.6Cr
EBITDAR	354.7Cr	360.4Cr	338.2Cr	365Cr	386.4Cr
Total Revenues (As Reported)	1.72TCr	1.76TCr	1.83TCr	1.96TCr	1.97TCr
Effective Tax Rate - (Ratio)	24.06	20.87	22.41	31.47	20.57
Current Domestic Taxes	32Cr	20Cr	49Cr	21Cr	7Cr
Current Foreign Taxes	46Cr	42Cr	32Cr	34Cr	41Cr
Total Current Taxes	78Cr	62Cr	82Cr	56Cr	48Cr
Deferred Domestic Taxes	30L	8.3Cr	-26Cr	8.2Cr	6.1Cr
Deferred Foreign Taxes	-13Cr	-10Cr	70L	10Cr	-1.2Cr
Total Deferred Taxes	-13Cr	-1.8Cr	-25Cr	18Cr	4.9Cr
Normalized Net Income	164.28Cr	175.09Cr	151.9Cr	123.6Cr	154.49Cr
Interest on Long-Term Debt	-	-	-	62Cr	58Cr
Non-Cash Pension Expense	40L	10L	-1Cr	-30Cr	-32Cr
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	81Cr	82Cr	102.6Cr	120.5Cr	131.1Cr
Net Rental Expense, Total	20Cr	18Cr	22Cr	23Cr	26Cr
Imputed Operating Lease Interest Expense	-	164.44Cr	3.29Cr	10Cr	9.93Cr
Imputed Operating Lease Depreciation	-	-145.94Cr	18Cr	13Cr	16Cr
Stock-Based Comp., Other (Total)	-	-	-	11Cr	12Cr
Total Stock-Based Compensation	-	-	-	11Cr	12Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	100.7Cr	56Cr	144Cr	249.4Cr	287.3Cr
Total Cash And Short Term Investments	100.7Cr	56Cr	144Cr	249.4Cr	287.3Cr
Accounts Receivable, Total	235.5Cr	366Cr	360.5Cr	384.1Cr	386.7Cr
Other Receivables	-	-	29Cr	32Cr	41Cr
Notes Receivable	12Cr	9.9Cr	9.7Cr	9.7Cr	9Cr
Total Receivables	248Cr	375.9Cr	399.3Cr	425.4Cr	436.3Cr
Inventory	159.4Cr	194.6Cr	215.5Cr	196Cr	193.9Cr
Prepaid Expenses	14Cr	16Cr	16Cr	15Cr	19Cr
Restricted Cash	-	-	50L	1Cr	1.6Cr
Other Current Assets, Total	67Cr	58Cr	56Cr	54Cr	52Cr
Total Current Assets	589.6Cr	700Cr	831.8Cr	941Cr	990.1Cr
Gross Property Plant And Equipment	489Cr	505.1Cr	530.2Cr	556.4Cr	563Cr
Accumulated Depreciation	-268.8Cr	-281.6Cr	-298.8Cr	-306.4Cr	-308Cr
Net Property Plant And Equipment	220.2Cr	223.5Cr	231.4Cr	250Cr	255Cr
Long-term Investments	34Cr	34Cr	32Cr	36Cr	37Cr
Goodwill	1.19TCr	1.29TCr	1.28TCr	1.29TCr	1.31TCr
Other Intangibles, Total	160.3Cr	184.7Cr	152Cr	125.3Cr	107.8Cr
Accounts Receivable Long-Term	1.5Cr	1.9Cr	8.6Cr	17Cr	21Cr
Loans Receivable Long-Term	23Cr	19Cr	20Cr	18Cr	18Cr
Deferred Tax Assets Long-Term	148.9Cr	128.7Cr	155Cr	447.4Cr	447.4Cr
Deferred Charges Long-Term	7.1Cr	7.7Cr	8.2Cr	-	-
Other Long-Term Assets, Total	51Cr	42Cr	34Cr	117.8Cr	118.6Cr
Total Assets	2.42TCr	2.63TCr	2.75TCr	3.25TCr	3.31TCr
Liabilities
Accounts Payable, Total	216.2Cr	254Cr	294.4Cr	294.7Cr	302.2Cr
Accrued Expenses, Total	-	-	133.3Cr	198.6Cr	203.5Cr
Short-term Borrowings	-	-	-	100.6Cr	20L
Current Portion of Long-Term Debt	40L	60L	1.5Cr	-	150Cr
Current Portion of Leases	-	-	10Cr	11Cr	12Cr
Current Income Taxes Payable	-	-	-	-	28Cr
Unearned Revenue Current, Total	181.3Cr	186.4Cr	189.6Cr	191.8Cr	194.3Cr
Other Current Liabilities	254.5Cr	235.1Cr	90Cr	101.4Cr	66Cr
Total Current Liabilities	652.4Cr	676.1Cr	719.1Cr	898.1Cr	955.3Cr
Long-Term Debt	3.1Cr	3.1Cr	823.4Cr	843.6Cr	744.9Cr
Long-Term Leases	-	-	28Cr	31Cr	31Cr
Unearned Revenue Non Current	-	-	63Cr	70Cr	69Cr
Pension & Other Post Retirement Benefits	80Cr	75Cr	55Cr	578.2Cr	558.3Cr
Deferred Tax Liability Non Current	46Cr	38Cr	37Cr	6.8Cr	5.6Cr
Other Non Current Liabilities	143.5Cr	148.4Cr	69Cr	86Cr	80Cr
Total Liabilities	925.4Cr	941.2Cr	1.79TCr	2.51TCr	2.44TCr
Common Stock, Total	1.56TCr	1.77TCr	1.12TCr	50L	50L
Additional Paid In Capital	-	-	-	649.3Cr	658.3Cr
Retained Earnings	-	-	-	132.6Cr	326.2Cr
Treasury Stock	-	-	-	-	-2.5Cr
Comprehensive Income and Other	-84Cr	-103.7Cr	-187.8Cr	-69Cr	-137.9Cr
Total Common Equity	1.47TCr	1.67TCr	935.7Cr	713.3Cr	844.6Cr
Minority Interest	25Cr	24Cr	24Cr	18Cr	21Cr
Total Equity	1.5TCr	1.69TCr	959.2Cr	731Cr	865.2Cr
Total Liabilities And Equity	2.42TCr	2.63TCr	2.75TCr	3.25TCr	3.31TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	-	-	45Cr	46Cr	46Cr
ECS Total Common Shares Outstanding	-	-	-	46Cr	46Cr
Book Value / Share	-	-	-	15.67	18.48
Tangible Book Value	125.6Cr	191.6Cr	-497.6Cr	-705.6Cr	-576.8Cr
Tangible Book Value Per Share	-	-	-	-15.5	-12.62
Total Debt	3.5Cr	3.7Cr	863.5Cr	986.3Cr	937.6Cr
Net Debt	-97Cr	-52Cr	719.5Cr	736.9Cr	650.3Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	51Cr	39Cr	28Cr	353Cr	354.4Cr
Debt Equivalent Oper. Leases	160.8Cr	148Cr	173.6Cr	183.2Cr	206.4Cr
Minority Interest, Total (Incl. Fin. Div)	25Cr	24Cr	24Cr	18Cr	21Cr
Equity Method Investments, Total	34Cr	34Cr	32Cr	36Cr	37Cr
Account Code - Inventory Valuation	-	5	5	5	5
Inventories - Raw Materials, Total	73Cr	90Cr	105.3Cr	96Cr	92Cr
Inventories - Work In Process, Total	6.2Cr	10Cr	9.1Cr	9.1Cr	9.2Cr
Inventories - Finished Goods, Total	81Cr	94Cr	101.1Cr	91Cr	93Cr
Land - (BS)	7Cr	7.7Cr	7Cr	7Cr	6.6Cr
Buildings, Total	173.6Cr	175.6Cr	188.9Cr	195.6Cr	194.3Cr
Machinery, Total	234.6Cr	246.6Cr	254.1Cr	261.7Cr	270.4Cr
Full Time Employees	-	51T	50T	51T	53T
Accumulated Allowance for Doubtful Accounts (Supple)	9.3Cr	11Cr	9.1Cr	9.8Cr	10Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	1.38TCr	224.7Cr	191.6Cr	138.5Cr	199.3Cr
Depreciation & Amortization - CF	22Cr	22Cr	23Cr	25Cr	27Cr
Amortization of Goodwill and Intangible Assets - (CF)	41Cr	40Cr	40Cr	36Cr	31Cr
Depreciation & Amortization, Total	63Cr	62Cr	63Cr	61Cr	58Cr
Stock-Based Compensation (CF)	-	-	-	11Cr	12Cr
Net Cash From Discontinued Operations	-93Cr	-	-2.1Cr	-	-40L
Other Operating Activities, Total	-1.19TCr	1.3Cr	-32Cr	-20Cr	-61Cr
Change In Accounts Receivable	-28Cr	-131.3Cr	-45Cr	-18Cr	-18Cr
Change In Inventories	10Cr	-44Cr	-40Cr	11Cr	-8.1Cr
Change In Accounts Payable	-11Cr	26Cr	48Cr	-1.3Cr	13Cr
Change in Unearned Revenues	31Cr	-2.1Cr	14Cr	2.6Cr	6.8Cr
Change in Other Net Operating Assets	6.6Cr	23Cr	14Cr	25Cr	-7.1Cr
Cash from Operations	168.7Cr	160.7Cr	211.3Cr	210.1Cr	195.1Cr
Capital Expenditure	-24Cr	-24Cr	-31Cr	-39Cr	-40Cr
Sale of Property, Plant, and Equipment	1.6Cr	1.5Cr	40L	10L	-
Cash Acquisitions	-7.8Cr	-148.1Cr	-	-15Cr	-31Cr
Sale (Purchase) of Intangible assets	-2.2Cr	-60L	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-	-4Cr
Other Investing Activities, Total	2.03TCr	-4.7Cr	-9.2Cr	-2.5Cr	-16Cr
Cash from Investing	2TCr	-176.1Cr	-40Cr	-56Cr	-91Cr
Short Term Debt Issued, Total	-	-	90L	-	-
Long-Term Debt Issued, Total	40L	50L	819.8Cr	200.6Cr	100Cr
Total Debt Issued	40L	50L	820.7Cr	200.6Cr	100Cr
Short Term Debt Repaid, Total	-1Cr	-70L	-	-1.2Cr	-
Long-Term Debt Repaid, Total	-1Cr	-1Cr	-30L	-86Cr	-141.8Cr
Total Debt Repaid	-2Cr	-1.7Cr	-30L	-87Cr	-141.8Cr
Issuance of Common Stock	-	-	-	-	3.3Cr
Repurchase of Common Stock	-	-	-	-	-9.3Cr
Common Dividends Paid	-	-	-	-4.1Cr	-5.5Cr
Common & Preferred Stock Dividends Paid	-	-	-	-4.1Cr	-5.5Cr
Other Financing Activities, Total	-2.15TCr	-25Cr	-902.6Cr	-157.6Cr	-3.5Cr
Cash from Financing	-2.15TCr	-26Cr	-82Cr	-48Cr	-57Cr
Foreign Exchange Rate Adjustments	1.4Cr	-3.4Cr	-30L	-1Cr	-7.7Cr
Net Change in Cash	14Cr	-45Cr	89Cr	105.5Cr	39Cr
Supplemental Items
Cash Interest Paid	4.6Cr	2.1Cr	-	57Cr	55Cr
Cash Income Tax Paid (Refund)	-	-	-	47Cr	49Cr
Levered Free Cash Flow	-	78Cr	184.08Cr	253.32Cr	186.49Cr
Unlevered Free Cash Flow	-	80Cr	189.45Cr	284.89Cr	215.42Cr
Change In Net Working Capital	-	132Cr	1.1Cr	-76Cr	4.1Cr
Net Debt Issued / Repaid	-1.6Cr	-1.2Cr	820.4Cr	113.9Cr	-42Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-	6.91	5.88	5.86	5.77
Return on Total Capital	-	10.93	8.9	9.93	10.75
Return On Equity %	-	14.28	14.72	19.15	25.69
Return on Common Equity	-	14.21	14.59	16.85	25.59
Margin Analysis
Gross Profit Margin %	39.43	40.8	39.14	40.52	41.71
SG&A Margin	18.88	20.27	19.74	19.98	19.66
EBITDA Margin %	19.49	19.44	17.26	17.5	18.33
EBITA Margin %	18.2	18.16	16.01	16.23	16.97
EBIT Margin %	15.82	15.89	13.81	14.38	15.38
Income From Continuing Operations Margin %	11.99	12.94	10.63	8.28	10.42
Net Income Margin %	80.67	12.78	10.45	7.08	10.13
Net Avail. For Common Margin %	11.69	12.68	10.35	7.1	10.13
Normalized Net Income Margin	9.57	9.96	8.28	6.32	7.85
Levered Free Cash Flow Margin	-	4.43	10.04	12.96	9.48
Unlevered Free Cash Flow Margin	-	4.57	10.33	14.57	10.95
Asset Turnover
Asset Turnover	-	0.7	0.68	0.65	0.6
Fixed Assets Turnover	-	7.93	8.06	8.12	7.79
Receivables Turnover (Average Receivables)	-	5.85	5.27	5.25	5.1
Inventory Turnover (Average Inventory)	-	5.88	5.44	5.65	5.88
Short Term Liquidity
Current Ratio	0.9	1.04	1.16	1.05	1.04
Quick Ratio	0.52	0.62	0.74	0.74	0.75
Operating Cash Flow to Current Liabilities	0.26	0.24	0.29	0.23	0.2
Days Sales Outstanding (Average Receivables)	-	62.42	69.24	69.5	71.7
Days Outstanding Inventory (Average Inventory)	-	62.05	67.05	64.57	62.22
Average Days Payable Outstanding	-	79.73	88.02	94.02	95.43
Cash Conversion Cycle (Average Days)	-	44.75	48.28	40.06	38.49
Long Term Solvency
Total Debt/Equity	0.23	0.22	90.02	134.92	108.37
Total Debt / Total Capital	0.23	0.22	47.37	57.43	52.01
LT Debt/Equity	0.21	0.18	88.78	119.66	89.68
Long-Term Debt / Total Capital	0.21	0.18	46.72	50.93	43.04
Total Liabilities / Total Assets	38.2	35.78	65.17	77.48	73.85
EBIT / Interest Expense	41.15	69.85	29.44	5.57	6.54
EBITDA / Interest Expense	50.7	85.48	39.33	7.23	8.35
(EBITDA - Capex) / Interest Expense	47.11	79.42	35.72	6.46	7.48
Total Debt / EBITDA	0.01	0.01	2.55	2.7	2.43
Net Debt / EBITDA	-0.29	-0.15	2.13	2.02	1.68
Total Debt / (EBITDA - Capex)	0.01	0.01	2.81	3.02	2.71
Net Debt / (EBITDA - Capex)	-0.31	-0.16	2.34	2.26	1.88
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	3.19	2.45	4.3	6.6	0.61
Gross Profit, 1 Yr. Growth %	3.34	6.01	0.07	10.35	3.57
EBITDA, 1 Yr. Growth %	20.58	2.18	-7.43	10.35	5.41
EBITA, 1 Yr. Growth %	22.51	2.24	-8.05	10.48	5.2
EBIT, 1 Yr. Growth %	28.36	2.87	-9.38	13.94	7.65
Earnings From Cont. Operations, 1 Yr. Growth %	22.43	10.54	-14.33	-16.98	26.7
Net Income, 1 Yr. Growth %	808.53	-83.77	-14.73	-27.71	43.9
Normalized Net Income, 1 Yr. Growth %	28.55	6.58	-13.24	-16.39	24.99
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-	-27.27	42.76
Accounts Receivable, 1 Yr. Growth %	-	55.41	7.48	6.55	0.68
Inventory, 1 Yr. Growth %	-	22.08	10.74	-9.05	-1.07
Net Property, Plant and Equip., 1 Yr. Growth %	-	1.5	3.53	8.04	2
Total Assets, 1 Yr. Growth %	-	8.59	4.68	17.85	1.96
Tangible Book Value, 1 Yr. Growth %	-	52.55	-359.71	41.8	-18.25
Common Equity, 1 Yr. Growth %	-	13.09	-43.82	-23.77	18.41
Cash From Operations, 1 Yr. Growth %	-15.18	-4.74	31.49	-0.57	-7.14
Capital Expenditures, 1 Yr. Growth %	-9.89	2.11	28.1	24.84	3.62
Levered Free Cash Flow, 1 Yr. Growth %	-	-	173.82	35.68	-26.38
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	171.71	48.31	-24.38
Dividend Per Share, 1 Yr. Growth %	-	-	-	-	4.17
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	2.82	3.37	5.44	3.56
Gross Profit, 2 Yr. CAGR %	-	4.67	3	5.08	6.91
EBITDA, 2 Yr. CAGR %	-	11	-2.74	0.03	7.85
EBITA, 2 Yr. CAGR %	-	11.92	-3.04	-0.33	7.81
EBIT, 2 Yr. CAGR %	-	14.91	-3.45	0.3	10.75
Earnings From Cont. Operations, 2 Yr. CAGR %	-	16.33	-2.68	-15.67	2.56
Net Income, 2 Yr. CAGR %	-	21.43	-62.8	-21.49	1.99
Normalized Net Income, 2 Yr. CAGR %	-	17.05	-3.84	-15.98	2.22
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-	-21.31	1.9
Accounts Receivable, 2 Yr. CAGR %	-	-	23.72	7.01	3.57
Inventory, 2 Yr. CAGR %	-	-	16.27	0.36	-5.14
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	2.51	5.76	4.98
Total Assets, 2 Yr. CAGR %	-	-	6.61	11.07	9.61
Tangible Book Value, 2 Yr. CAGR %	-	-	99.04	91.9	7.66
Common Equity, 2 Yr. CAGR %	-	-	-20.29	-34.56	-4.99
Cash From Operations, 2 Yr. CAGR %	-	-10.11	11.92	14.34	-3.91
Capital Expenditures, 2 Yr. CAGR %	-	-4.08	14.37	24.92	13.73
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	84	-0.06
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	91.94	5.9
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	3.31	4.44	3.81
Gross Profit, 3 Yr. CAGR %	-	-	3.11	5.39	4.58
EBITDA, 3 Yr. CAGR %	-	-	4.48	0.74	1.79
EBITA, 3 Yr. CAGR %	-	-	4.82	0.52	1.48
EBIT, 3 Yr. CAGR %	-	-	6.17	1.15	2.69
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	5.05	-7.71	-3.41
Net Income, 3 Yr. CAGR %	-	-	7.93	-53.58	-3.92
Normalized Net Income, 3 Yr. CAGR %	-	-	5.93	-9.05	-4.09
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-	-4.03
Accounts Receivable, 3 Yr. CAGR %	-	-	-	17.71	4.86
Inventory, 3 Yr. CAGR %	-	-	-	7.13	-0.12
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	4.32	4.49
Total Assets, 3 Yr. CAGR %	-	-	-	10.23	7.94
Tangible Book Value, 3 Yr. CAGR %	-	-	-	77.77	44.39
Common Equity, 3 Yr. CAGR %	-	-	-	-21.47	-20.26
Cash From Operations, 3 Yr. CAGR %	-	-	2.04	7.59	6.68
Capital Expenditures, 3 Yr. CAGR %	-	-	5.63	17.76	17.37
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	35.58
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	40.71
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	3.41
Gross Profit, 5 Yr. CAGR %	-	-	-	-	4.62
EBITDA, 5 Yr. CAGR %	-	-	-	-	5.38
EBITA, 5 Yr. CAGR %	-	-	-	-	5.53
EBIT, 5 Yr. CAGR %	-	-	-	-	7.42
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	4.05
Net Income, 5 Yr. CAGR %	-	-	-	-	5.51
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	3.87
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	-0.39
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	8.8